Kiniksa Pharmaceuticals (KNSA) Price/Sales Ratio
Market Cap: $1.66B
Avg Volume: 594.50K
Industry: Biotechnology
Sector: Healthcare
What is Kiniksa Pharmaceuticals's Price/Sales Ratio?
- Kiniksa Pharmaceuticals's trailing twelve month (TTM) Price/Sales ratio is 3.93.
- Kiniksa Pharmaceuticals's annual Price/Sales ratio as of today is 3.34.
- Kiniksa Pharmaceuticals's quarterly Price/Sales ratio is 11.53.
What is the Price/Sales Ratio?
The Price/Sales ratio (P/S ratio) is a valuation metric that compares a company's stock price to its revenues. A lower P/S ratio may indicate that a stock is undervalued.
How is the Price/Sales Ratio calculated?
The Price/Sales ratio is calculated by dividing the company's market capitalization by its total sales or revenue. The formula is:
P/S Ratio = Market Capitalization / Total Sales (Revenue)
Related Metrics
Other important metrics to assess Kiniksa Pharmaceuticals's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: -32.71
- Quarterly: -39.74
- TTM: -37.82
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 3.22
- Quarterly: 3.22
- TTM: 3.73
- P/C Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: 55.00
- Quarterly: 75.27
- TTM: 63.59
- PEG Ratio (Price/Earnings to Growth Ratio) - measures the company's valuation considering its earnings growth:
- Annual: 0.08
- Quarterly: 1.19
- TTM: 0.09
These metrics provide insights into Kiniksa Pharmaceuticals's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Price/Sales Ratio
3.34
Quarterly Price/Sales Ratio
11.53
TTM Price/Sales Ratio
3.93
Kiniksa Pharmaceuticals Historical Price/Sales Ratio
Historical P/E Ratio
Historical P/B Ratio
Historical P/C Ratio
Historical PEG Ratio
Kiniksa Pharmaceuticals Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Price/Sales Ratio | P/E Ratio | P/B Ratio | P/C Ratio | PEG Ratio |
|---|---|---|---|---|---|
| 2024 | 3.34 | -32.71 | 3.22 | 55.00 | 0.08 |
| 2023 | 4.55 | 87.25 | 2.80 | 92.39 | -0.94 |
| 2022 | 4.72 | 5.67 | -2.11 | 178.98 | -0.03 |
| 2021 | 20.94 | -5.11 | -1.20 | -6.39 | 0.43 |
| 2020 | 0.00 | -6.77 | -2.11 | -8.00 | 0.53 |
| 2019 | 0.00 | -3.69 | -1.68 | -3.77 | 0.26 |
| 2018 | 0.00 | -8.04 | -4.27 | -10.25 | -0.11 |
| 2017 | 0.00 | -9.74 | -7.05 | -12.59 | -0.06 |
| 2016 | 0.00 | -26.37 | -24.57 | -28.91 | 0.00 |
Related Metrics
Explore detailed financial metrics and analysis for KNSA.